| Scrip Code | 539871 |
|---|---|
| NSE Symbol | THYROCARE |
| MSEI Symbol | NOTLISTED |
| ISIN | INE594H01019 |
| Name of company | Thyrocare Technologies Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 23-07-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 16-07-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 23-07-2026 14:45:00 |
| End date and time of board meeting | 23-07-2026 15:35:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 24,002.00 | 24,002.00 | |
| Other income | 415.00 | 415.00 | |
| Total income | 24,417.00 | 24,417.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 6,188.00 | 6,188.00 |
| (b) | Purchases of stock-in-trade | 3.00 | 3.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 25.00 | 25.00 |
| (d) | Employee benefit expense | 3,961.00 | 3,961.00 |
| (e) | Finance costs | 135.00 | 135.00 |
| (f) | Depreciation, depletion and amortisation expense | 1,249.00 | 1,249.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 6,098.00 | 6,098.00 |
| Total other expenses | 6,098.00 | 6,098.00 | |
| Total expenses | 17,659.00 | 17,659.00 | |
| 3 | Total profit before exceptional items and tax | 6,758.00 | 6,758.00 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 6,758.00 | 6,758.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 1,848.00 | 1,848.00 |
| 8 | Deferred tax | (152.00) | (152.00) |
| 9 | Total tax expenses | 1,696.00 | 1,696.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 5,062.00 | 5,062.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 71.00 | 71.00 |
| 16 | Total profit (loss) for period | 5,133.00 | 5,133.00 |
| 17 | Other comprehensive income net of taxes | 39.00 | 39.00 |
| 18 | Total Comprehensive Income for the period | 5,172.00 | 5,172.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 5,219.00 | 5,219.00 | |
| Total profit or loss, attributable to non-controlling interests | (86.00) | (86.00) | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 5,258.00 | 5,258.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (86.00) | (86.00) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 15,917.00 | 15,917.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 3.23 | 3.23 | |
| Diluted earnings (loss) per share from continuing operations | 3.22 | 3.22 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 3.23 | 3.23 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 3.22 | 3.22 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | As per Signed Financial Results. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Diagnostic Testing Services | 22,621.00 | 22,621.00 | ||||
| 2 | Imaging Services | 1,348.00 | 1,348.00 | ||||
| 3 | Others | 0.00033 | 0.00033 | ||||
| Total Segment Revenue | 24,002.00 | 24,002.00 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 24,002.00 | 24,002.00 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Diagnostic Testing Services | 6,190.00 | 6,190.00 | ||||
| 2 | Imaging Services | 126.00 | 126.00 | ||||
| 3 | Others | 27.00 | 27.00 | ||||
| Total Profit before tax | 6,343.00 | 6,343.00 | |||||
| i. Finance cost | 0.00 | 0.00 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | (415.00) | (415.00) | |||||
| Profit before tax | 6,758.00 | 6,758.00 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Diagnostic Testing Services | 58,612.00 | 58,612.00 | ||||
| 2 | Imaging Services | 20,394.00 | 20,394.00 | ||||
| 3 | Others | 0.00 | 0.00 | ||||
| Total Segment Asset | 79,006.00 | 79,006.00 | |||||
| Un-allocable Assets | 4,304.00 | 4,304.00 | |||||
| Net Segment Asset | 83,310.00 | 83,310.00 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Diagnostic Testing Services | 17,589.00 | 17,589.00 | ||||
| 2 | Imaging Services | 1,187.00 | 1,187.00 | ||||
| 3 | Others | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 18,776.00 | 18,776.00 | |||||
| Un-allocable Liabilities | 238.00 | 238.00 | |||||
| Net Segment Liabilities | 19,014.00 | 19,014.00 | |||||
| Disclosure of notes on segments | Textual Information(2) | ||||||
| Textual Information(2) | As per Signed Financial Results. |
|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement of defined benefit (liability)/asset | 39.00 | 39.00 |
| Total Amount of items that will not be reclassified to profit and loss | 39.00 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.00 | 0.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | 39.00 | 39.00 |